FDA’s First Chief Scientist Is Wake Forest Oncologist Frank Torti
Executive Summary
FDA's new Chief Scientist Frank Torti will be asked to concentrate on clinical research when he assumes the newly created position in May, FDA announced April 9
You may also be interested in...
FDA’s Von Eschenbach Returns To Texas In January; Will He Also Return To MD Anderson?
Von Eschenbach’s resignation is effective Jan. 20; FDA commissioner expresses hope that senior team will remain at least partly intact.
FDA Chief Scientist Torti’s Plan For First 100 Days Centers On Excellence
FDA's newly appointed Chief Scientific Officer Frank Torti will focus on collaborations with industry and academia in order to boost the agency's scientific expertise and augment scarce resources, he said at a May 30 Science Board Meeting
FDA Chief Scientist Torti’s Plan For First 100 Days Centers On Excellence
FDA's newly appointed Chief Scientific Officer Frank Torti will focus on collaborations with industry and academia in order to boost the agency's scientific expertise and augment scarce resources, he said at a May 30 Science Board Meeting